Company intelligence / Profile preview

Emfit

Mikkeli or Salo, Finnish Republic (Finland)emfit.com ↗

Ownership: Private
Development stage: Commercial

Overview

Emfit’s ballistocardiography-based, contact-free sensors are clinically validated and commercially available for continuous, non-intrusive monitoring of vital signs such as heart rate, breathing rate, heart rate variability, and movement. Their solutions are widely used in elderly care for fall and wandering prevention, in epilepsy management for seizure detection during sleep, and in wellness/sleep quality tracking. Over 100 scientific publications support their efficacy.

Therapeutic areas: OtherNeurology
Modalities: Device (contact-free sensor)Non-pharmacological therapy (monitoring)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Emfit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emfit.

Explore the full profile